European Psychiatry: Volume 17 - Issue S1

European Psychiatry

Only show content I have access to (961)

Over 3 years (961)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 17 - Issue S1 - May 2002

P03. Anxiolytics

Posters, Sunday, 5 May 2002

Patient and observer perspectives on venlafaxine ER efficacy in GAD

Do baseline gastrointestinal symptoms alter venlafaxine ER efficacy?

Duration of treatment with venlafaxine ER in GAD

P04. Bipolar disorders

Posters, Sunday, 5 May 2002

Construct validity of affective temperament questionnaire: data from the National French Study “EPIDEP”

Pure versus dysphoric mixed mania: 12-month prospective follow-up data from the French National EPIMAN Study

Frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France

Olanzapine cotherapy in prevention of recurrence in bipolar disorder

Olanzapine versus divalproex sodium for bipolar mania: a 47-week study

Case report of 5 bipolar disorder patients (Rapid Cycling) followed for 3 years, treated with lamotrigine

The bipolar spectrum disorders: implications for new drug development

Obstetric complications as risk factors for bipolar disorder

P05. Brain imaging - structural

Posters, Sunday, 5 May 2002

A diffusion tensor and metabolite spectroscopic imaging study of white matter connectivity in schizophrenia

Magnetic resonance tomography (MRT) of brain of serial sexual sadists

Progression of hippocampal atrophy is associated with clinical deterioration in Alzheimer’s disease

MR volumetry during acute alcohol withdrawal and abstinence

Reliability and reproducibility of MR brain tissue segmentation

Cerebellar vermis volume reduction in patients with chronic schizophrenia

P06. Brain imaging - functional

Posters, Sunday, 5 May 2002

Vagus nerve stimulation and fMRI in treatment-resistant depression

An EEG study of visual-sensory integration in schizophrenia

Effects of VNS on rCBF in patients with treatment-resistant depression

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 17 - Issue S1 - May 2002

P03. Anxiolytics

Posters, Sunday, 5 May 2002

P04. Bipolar disorders

Posters, Sunday, 5 May 2002

P05. Brain imaging - structural

Posters, Sunday, 5 May 2002

P06. Brain imaging - functional

Posters, Sunday, 5 May 2002